Tested Applications
| Positive WB detected in | HL-60 cells |
| Positive IHC detected in | human breast cancer tissue, human liver tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:200-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
13922-1-AP targets PTPRE in WB, IHC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag4932 Product name: Recombinant human PTPRE protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 351-700 aa of BC050062 Sequence: MMAMMHAEQKVDVFEFVSRIRNQRPQMVQTDMQYTFIYQALLEYYLYGDTELDVSSLEKHLQTMHGTTTHFDKIGLEEEFRKLTNVRIMKENMRTGNLPANMKKARVIQIIPYDFNRVILSMKRGQEYTDYINASFIDGYRQKDYFIATQGPLAHTVEDFWRMIWEWKSHTIVMLTEVQEREQDKCYQYWPTEGSVTHGEITIEIKNDTLSEAISIRDFLVTLNQPQARQEEQVRVVRQFHFHGWPEIGIPAEGKGMIDLIAAVQKQQQQTGNHPITVHCSAGAGRTGTFIALSNILERVKAEGLLDVFQAVKSLRLQRPHMVQTLEQYEFCYKVVQDFIDIFSDYANFK Predict reactive species |
| Full Name | protein tyrosine phosphatase, receptor type, E |
| Calculated Molecular Weight | 81 kDa |
| Observed Molecular Weight | 81 kDa |
| GenBank Accession Number | BC050062 |
| Gene Symbol | PTPRE |
| Gene ID (NCBI) | 5791 |
| RRID | AB_2174672 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P23469 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for PTPRE antibody 13922-1-AP | Download protocol |
| WB protocol for PTPRE antibody 13922-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The PTPRE Polyclonal antibody (Cat# 13922-1-AP) has 3 citations. They appear in Biomedical Pharmacotherapy, Clinical Epigenetics, and Frontiers in Oncology. The research fields span hepatocellular carcinoma (tumor progression, sorafenib response, and intrahepatic metastasis) and proliferative diabetic retinopathy (neovascularization). Applications include IHC and Western blot, all in human samples.
| Species | Application | Title |
|---|---|---|
Biomed Pharmacother Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellular carcinoma | ||
Clin Epigenetics TET2-mediated ECM1 hypomethylation promotes the neovascularization in active proliferative diabetic retinopathy | ||
Front Oncol miR-631 Inhibits Intrahepatic Metastasis of Hepatocellular Carcinoma by Targeting PTPRE.
|









